Genworth Financial Stock Earnings Reports

Genworth reported solid third-quarter 2025 results driven primarily by strong performance at Enact (mortgage insurance), with consolidated net income of $116 million and adjusted operating income of $17 million ($0.04 per share). Enact contributed $134 million to adjusted operating income and returned $110 million of capital in the quarter (bringing total returns since IPO to $1.2 billion); Enact now expects to return approximately $500 million in 2025, which increases Genworth's expected benefit given its ~81% ownership. Genworth announced a new $350 million share repurchase authorization and now expects to allocate $200–$225 million to buybacks in 2025. The company continues execution on its three strategic priorities: (1) monetize and create shareholder value via Enact; (2) manage the legacy long-term care (LTC), life and annuity books via an ongoing multiyear rate action plan (MYRAP) — which has achieved ~$31.8 billion NPV of in-force rate actions — and (3) grow CareScout (services and insurance), including the Seniorly acquisition and launch of CareScout Assurance (approved in 37 states). LTC statutory/GAAP results remain pressured by higher benefit utilization and lower terminations, producing an LTC adjusted operating loss driven by unfavorable actual vs. expected experience; however, management reiterates the legacy LTC block will be managed as a closed, self-sustaining business (no parent capital planned). Holding company liquidity was $254 million of cash and liquid assets at quarter end, holding company debt is $790 million with ~7x cash interest coverage, and Genworth continues to prioritize investing in CareScout, share repurchases (when shares trade below intrinsic value), and opportunistic debt repayment. Management remains confident in potential AXA litigation recoveries (~$750 million if upheld) but is not counting those proceeds in current capital plans.